1.Etiology, Pathogenesis, Syndrome Differentiation and Treatment Rules of Chronic Obstructive Pulmonary Disease in Traditional Chinese Medicine
Qinjun YANG ; Mingxiang HAN ; Limei WEI ; Shuyu XU ; Lu ZHANG ; Cheng YANG ; Jiabing TONG ; Zegeng LI
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):226-234
Chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by airflow limitation, and its high morbidity and disability rates pose a severe challenge to global public health. Traditional Chinese medicine (TCM) has demonstrated definite efficacy and distinctive characteristics in the treatment of COPD. Based on the understanding of ancient and modern physicians regarding the etiology, pathogenesis, and stage-based syndrome differentiation of COPD, this article systematically elaborates on the etiology, pathogenesis, and clinical principles of syndrome differentiation and treatment of COPD. COPD is characterized by deficiency at root and excess in manifestation, with the coexistence of deficiency and excess. Qi deficiency is the fundamental pathogenesis underlying the occurrence and development of COPD and runs throughout the entire disease course. The disease begins with deficiency of lung qi and gradually affects the spleen and kidney, leading to the internal generation of dampness, phlegm, and blood stasis. Phlegm and blood stasis are not only pathological products but also deep-rooted causes of recurrent disease. Together with qi deficiency, they are mutually causal and form a vicious cycle. During the acute exacerbation stage of COPD, phlegm and blood stasis constitute the predominant underlying pathology and are often induced by invasion of pathogenic factors due to deficiency of healthy Qi. In addition, innovative understandings of the etiology and pathogenesis of COPD have emerged from the perspectives of collateral disease, latent pathogens, smoke toxins, and dysfunction of the Shaoyang pivot. During the stable stage, deficiency of Qi in the lung, spleen, and kidney predominates and is often accompanied by phlegm and blood stasis. In the clinical differentiation and treatment of COPD, treatment should be based on different disease stages and syndrome characteristics. During the acute exacerbation stage, eliminating pathogenic factors is the primary principle, with treatment determined according to syndrome differentiation. For wind-cold attacking the lung, the treatment is to ventilate the lung, disperse cold, and relieve cough. For phlegm-dampness accumulating in the lung, the treatment is to dry dampness, resolve phlegm, and direct qi downward. For phlegm-heat obstructing the lung, the treatment is to clear the lung, resolve phlegm, and relieve asthma. For phlegm and blood stasis obstructing the lung, the treatment is to eliminate phlegm, remove blood stasis, and relieve asthma. During the stable stage, reinforcing healthy Qi is the key principle. For lung-spleen qi deficiency, the treatment is to tonify the lung and strengthen the spleen, resolve phlegm, and direct Qi downward to relieve asthma. For deficiency of both lung and kidney, the treatment is to tonify the lung and benefit the kidney, resolve phlegm, promote Qi reception, and relieve asthma. When accompanied by phlegm and blood stasis, the treatment should focus on tonifying deficiency, resolving phlegm, and removing blood stasis. This article aims to systematically summarize the TCM etiology, pathogenesis, syndrome differentiation and treatment principles of COPD, as well as the current shortcomings in related research, in order to provide a reference for the clinical treatment of COPD with TCM, give full play to the advantages of TCM in the prevention and treatment of COPD, and optimize the whole-course management of COPD.
2.Etiology, Pathogenesis, Syndrome Differentiation and Treatment Rules of Chronic Obstructive Pulmonary Disease in Traditional Chinese Medicine
Qinjun YANG ; Mingxiang HAN ; Limei WEI ; Shuyu XU ; Lu ZHANG ; Cheng YANG ; Jiabing TONG ; Zegeng LI
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):226-234
Chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by airflow limitation, and its high morbidity and disability rates pose a severe challenge to global public health. Traditional Chinese medicine (TCM) has demonstrated definite efficacy and distinctive characteristics in the treatment of COPD. Based on the understanding of ancient and modern physicians regarding the etiology, pathogenesis, and stage-based syndrome differentiation of COPD, this article systematically elaborates on the etiology, pathogenesis, and clinical principles of syndrome differentiation and treatment of COPD. COPD is characterized by deficiency at root and excess in manifestation, with the coexistence of deficiency and excess. Qi deficiency is the fundamental pathogenesis underlying the occurrence and development of COPD and runs throughout the entire disease course. The disease begins with deficiency of lung qi and gradually affects the spleen and kidney, leading to the internal generation of dampness, phlegm, and blood stasis. Phlegm and blood stasis are not only pathological products but also deep-rooted causes of recurrent disease. Together with qi deficiency, they are mutually causal and form a vicious cycle. During the acute exacerbation stage of COPD, phlegm and blood stasis constitute the predominant underlying pathology and are often induced by invasion of pathogenic factors due to deficiency of healthy Qi. In addition, innovative understandings of the etiology and pathogenesis of COPD have emerged from the perspectives of collateral disease, latent pathogens, smoke toxins, and dysfunction of the Shaoyang pivot. During the stable stage, deficiency of Qi in the lung, spleen, and kidney predominates and is often accompanied by phlegm and blood stasis. In the clinical differentiation and treatment of COPD, treatment should be based on different disease stages and syndrome characteristics. During the acute exacerbation stage, eliminating pathogenic factors is the primary principle, with treatment determined according to syndrome differentiation. For wind-cold attacking the lung, the treatment is to ventilate the lung, disperse cold, and relieve cough. For phlegm-dampness accumulating in the lung, the treatment is to dry dampness, resolve phlegm, and direct qi downward. For phlegm-heat obstructing the lung, the treatment is to clear the lung, resolve phlegm, and relieve asthma. For phlegm and blood stasis obstructing the lung, the treatment is to eliminate phlegm, remove blood stasis, and relieve asthma. During the stable stage, reinforcing healthy Qi is the key principle. For lung-spleen qi deficiency, the treatment is to tonify the lung and strengthen the spleen, resolve phlegm, and direct Qi downward to relieve asthma. For deficiency of both lung and kidney, the treatment is to tonify the lung and benefit the kidney, resolve phlegm, promote Qi reception, and relieve asthma. When accompanied by phlegm and blood stasis, the treatment should focus on tonifying deficiency, resolving phlegm, and removing blood stasis. This article aims to systematically summarize the TCM etiology, pathogenesis, syndrome differentiation and treatment principles of COPD, as well as the current shortcomings in related research, in order to provide a reference for the clinical treatment of COPD with TCM, give full play to the advantages of TCM in the prevention and treatment of COPD, and optimize the whole-course management of COPD.
3.Exploration of interprofessional collaboration and translation model in medical social work
Wei LU ; Limei LIN ; Shiyao CHEN ; Fei XU ; Rongjian YU
Chinese Medical Ethics 2026;39(10):1374-1384
As the medical model shifts toward the “bio-psycho-social” paradigm, interprofessional collaboration has become a significant trend in the medical field. Medical social work, as a key role in interprofessional teams, still faces challenges related to localization, professionalization, and specialization in its practice within hospital settings. From the perspective of “translation,” which serves as a critical step in actor-network theory, this study explored the behavioral logic and interest interactions among actors in interprofessional collaboration, and analyzed and summarized effective service models of interprofessional collaboration to address service dilemmas, with a particular focus on the role of medical social workers. Based on the current status of peritoneal dialysis patient services at Hospital Z, this study selected various subjects of interprofessional collaboration as the research participants. A total of 19 network actors were interviewed using purposive random sampling and snowball sampling. Semi-structured interviews and non-participant observation were employed as research methods, with a particular focus on observing the operational process of interaction and translation mechanisms among interprofessional collaboration subjects. Thematic analysis was conducted, with coding performed using NVivo 14 software. From the translation perspective, the study analyzed the collaboration model of the interprofessional team in the treatment and rehabilitation process of peritoneal dialysis patients, highlighting the special role of medical social workers therein. The implementation of the collaborative model often encountered challenges related to professional boundaries, power boundaries, and institutional boundaries, which affected the translation process across the entire trajectory. Discussions were further conducted on dimensions such as optimizing the flow mechanisms of power and discourse, as well as forming supportive policies and formalized collaborative mechanisms.
4.Study on the efficacy and safety of eravacycline in ICU patients with multidrug-resistant bacterial pneumonia
Chunsu LIANG ; Limei LI ; Tingting XU ; Wei ZUO
China Pharmacy 2026;37(19):2566-2569
OBJECTIVE To evaluate the clinical efficacy and safety of eravacycline in intensive care unit (ICU) patients with carbapenem-resistant Acinetobacter baumannii (CRAB) and/or carbapenem-resistant Klebsiella pneumoniae (CRKP) pneumonia.METHODS Clinical data of patients with CRAB and/or CRKP pneumonia who were admitted to the ICU of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and received eravacycline treatment from July 2023 to November 2024 were collected. The 28-day all-cause mortality rate, clinical failure rate, 28-day ICU-free days among surviving patients, 28-day mechanical ventilation-free days among surviving patients, microbiological clearance, and adverse reactions were recorded.RESULTS A total of 37 patients were included. Among the 37 patients, 11 (29.73%) experienced clinical failure, and the 28-day all-cause mortality rate was 18.92% (7/37). The 28-day ICU-free days among surviving patients were (14.60±10.61) days, and the 28-day mechanical ventilation-free days among surviving patients were (24.55±4.29) days. Microbiological clearance was achieved in 12 patients (32.43%), and the mean time to conversion was (10.58±12.05) days. Adverse reactions occurred in 5 patients (13.51%), including 2 cases of elevated liver enzymes, 2 cases of coagulopathy, and 1 case of drug hypersensitivity syndrome.CONCLUSIONS Eravacycline can effectively control systemic bacterial infection and inflammatory response in ICU patients with pneumonia caused by CRAB and/or CRKP. However, patients with underlying liver disease or receiving multiple antibacterial agents should be alert to elevated liver enzymes, coagulation abnormalities, and the rare drug hypersensitivity syndrome.
5.Effect of serum HBV RNA on antiviral therapy in patients with chronic hepatitis B
Hongjing YIN ; Limei LI ; Xia CHENG ; Ying XU
Journal of Clinical Hepatology 2025;41(10):2030-2036
ObjectiveTo investigate the role of serum HBV RNA in assessing antiviral therapy for patients with chronic hepatitis B, as well as its potential as a biomarker in clinical therapy, and to provide a scientific basis for the clinical treatment of chronic hepatitis B. MethodsA total of 134 patients who were diagnosed with chronic HBV infection in The Second Affiliated Hospital of Kunming Medical University from April 2023 to May 2024 were enrolled as subjects, and related examinations were performed, including HBV DNA, serum HBV RNA, liver function, HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc, and transient elastography of the liver. The independent-samples t test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the Kruskal-Wallis H test was used for comparison between multiple groups; the chi-square test or the continuity-adjusted chi-square test was used for comparison of categorical data between two groups. Pearson correlation analysis or Spearman correlation analysis was performed. ResultsThe 134 patients with chronic HBV infection were divided into HBeAg-positive group with 45 patients and HBeAg-negative group with 89 patients, and there were significant differences between the two groups in age, the positive rate and quantitative value of HBV DNA, the positive rate and quantitative value of serum HBV RNA, HBsAg, anti-HBe, and ALT (all P<0.05). In the cohort study of the HBeAg negative group, there were significant differences in the levels of HBV DNA, HBsAg, and GGT between the serum HBV RNA-negative group with 14 patients and the serum HBV RNA-positive group with 75 patients (all P<0.05). There were 28 patients in the HBeAg-positive group and 62 in the HBeAg-positive group who used antiviral drugs for ≥1 month, and the 28 HBeAg-positive patients had an HBV RNA positive rate of 100%, while for the 62 HBeAg-negative patients, there were significant differences in the positive rate and level of serum HBV RNA between the patients with different durations of medication (both P<0.05). Among the 89 HBeAg-negative patients, there were 62 treatment-experienced patients and 27 treatment-naïve patients, and there was a significant difference between the two groups in HBV RNA level [2.07 (1.52 — 2.82) log10 copies/mL vs 2.69 (1.80 — 3.55) log10 copies/mL, Z=2.034, P=0.042]. For HBeAg-negative patients, serum HBV RNA was positively correlated with HBV DNA and HBsAg (both P<0.05), and for HBeAg-positive patients, serum HBV RNA was significantly positively correlated with HBV DNA, HBsAg, and HBeAg (all P<0.05). ConclusionAntiviral therapy can reduce viral load, and for HBeAg-negative patients with high-sensitivity HBV DNA below the lower limit of detection, serum HBV RNA can fill the “gap” in the detection of viral replication.
6.Application of 3D-HRAM model in diagnosis and localization of anal sphincter injury after surgery for complex anal fistula
Xuxiong WU ; Limei XU ; Juan HUANG ; Yaling YANG ; Zhaochu WANG ; Ruiwen LIANG ; Rong SHI
Journal of Chongqing Medical University 2025;50(6):821-827
Objective:To explore the application value of three-dimensional high-resolution anorectal manometry(3D-HRAM)model in the diagnosis and localization of anal sphincter injury after surgery for complex anal fistula.Methods:A prospective study was con-ducted on 92 patients who had undergone surgery for complex anal fistula in the Department of Coloproctology of The People's Hospi-tal Affiliated to Fujian University of Traditional Chinese Medicine from January 2023 to January 2024.The study was conducted in two stages.In the first stage,92 patients underwent 3D-HRAM and endoanal ultrasonography(EAUS)to examine the sphincter,and the data were compared with intraoperative records to evaluate the diagnostic efficiency and localization accuracy of 3D-HRAM and EAUS.In the second stage,92 patients who had been examined were grouped according to the presence or absence of symptoms of anal dysfunction to further verify the diagnostic and localization values of 3D-HRAM and EAUS for postoperative compensated/decompen-sated sphincter injury.Results:Among 92 patients,41 and 57 patients were diagnosed with sphincter injury through 3D-HRAM and EAUS,with a sensitivity of 61.19%and 85.07%,a specificity of 88%and 76%,an area under the curve of 0.739 and 0.813 calcu-lated by plotting the receiver operating characteristic curve,and a localization accuracy of 44.77%and 71.64%,respectively,showing significant differences between 3D-HRAM and EAUS(P=0.002),indicating that 3D-HRAM had lower diagnostic efficiency and local-ization accuracy than EAUS for anal sphincter injury after surgery for complex anal fistula.After grouping by symptoms,the diagnostic efficiency and localization accuracy of 3D-HRAM for symptomatic sphincter injury(decompensated)were significantly better than those for asymptomatic sphincter injury,and were similar to those of EAUS(P=0.763).Conclusion:The application advantage of 3D-HRAM lies in the diagnosis and localization of decompensated anal sphincter injury after surgery for complex anal fistula,which provides effective technical support for the study of anal defecation control mechanisms and injury compensation mechanisms.
7.Mechanism of Acupuncture at"Yanglingquan"and"Zusanli"in Regulating PINK1/Parkin-Mediated Mitophagy to Protect Chondrocytes in Rats with Knee Osteoarthritis
Weihua XUE ; Fangfang LUO ; Chuzhen LIN ; Limei XU
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(6):1446-1453
Objective To observe the therapeutic effects and mechanisms of acupuncture at"Yanglingquan"(GB34)and"Zusanli"(ST36)on knee osteoarthritis(KOA)rats,focusing on the regulation of PTEN-induced kinase 1/Parkin(PINK1/Parkin)-mediated mitophagy in chondrocytes.Methods Ten out of 40 male SD rats were randomly selected as the normal group,and the remaining 30 rats were used to construct a KOA model.A total of 27 rats were successfully modeled.The successfully modeled rats were randomly divided into a model group,an acupuncture group(acupuncture at Yanglingquan and Zusanli),and an acupuncture+autophagy inhibitor(3-MA)group(acupuncture at Yanglingquan and Zusanli combined with intraperitoneal injection of 3-MA),with 9 rats in each group.After intervention,the morphology of cartilage tissue in each group was observed,and the Mankin's score of cartilage was assessed.The apoptosis rate of chondrocytes was calculated.Enzyme-linked immunosorbent assay(ELISA)was used to detect inflammatory factors[cyclooxygenase 2(COX-2),interleukin 1β(IL-1β),and tumor necrosis factor α(TNF-α)],oxidative damage indicators[nitric oxide(NO),superoxide dismutase(SOD),malondialdehyde(MDA),and glutathione peroxidase(GSH-Px)],and the levels of matrix metalloproteinase 3(MMP-3)and tissue inhibitor of metalloproteinase 1(TIMP-1).The DHE probe was used to measure reactive oxygen species(ROS)level.Polymerase chain reaction(PCR)was used to detect the mRNA expression levels of PTEN-induced kinase 1(PINK1),Parkin,and microtubule-associated protein 1 light chain 3-Ⅱ(LC3-Ⅱ)in cartilage tissue.Western blot was used to measure the protein expression levels of PINK1,Parkin,and LC3-Ⅱ in cartilage tissue.Results Compared with the normal group,the model group showed increased Mankin's score,apoptosis rate,COX-2 level,IL-1β and TNF-α levels,NO and MDA levels,MMP-3 and TIMP-1 levels,and ROS content,as well as decreased SOD and GSH-Px levels,and reduced mRNA and protein expressions of PINK1,Parkin and LC3-Ⅱ,with statistically significant differences(P<0.05).Compared with the model group,the acupuncture group showed decreased Mankin's score,apoptosis rate,COX-2 level,IL-1β and TNF-α levels,NO and MDA levels,MMP-3 and TIMP-1 levels,and ROS content,as well as increased SOD and GSH-Px levels,and elevated mRNA and protein expressions of PINK1,Parkin and LC3-Ⅱ,with statistically significant differences(P<0.05).Compared with the acupuncture group,the acupuncture+3-MA group showed increased Mankin's score,apoptosis rate,COX-2 level,IL-1β and TNF-α levels,NO and MDA levels,MMP-3 and TIMP-1 levels,and ROS content,as well as decreased SOD and GSH-Px levels,and mRNA and protein expressions of PINK1,Parkin and LC3-Ⅱ,with statistically significant differences(P<0.05).Conclusion Acupuncture at"Yanglingquan"and"Zusanli"can inhibit chondrocyte apoptosis by activating PINK1/Parkin-mediated mitophagy,thus improving the condition of KOA rats.
8.Clinical Experience of Qin Zhenhua in Treating Cutaneous Pruritus
Limei ZHU ; Yiban XU ; Junfeng TANG ; Jia LIN ; Wenliang ZHONG ; Zhenhua QIN
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(10):2578-2583
This study summarizes Professor Qin Zhenhua's clinical experience in treating cutaneous pruritus using a modified self-prescribed formula,Yinqiao Xingzi Decoction.Following the viewpoints from the classical Chinese medical literature and after years of clinical practice,Professor Qin proposes that the onset of cutaneous pruritus is often associated with the attack of exogenous pathogens,disharmony of qi and blood,or debility due to prolonged illness.The disease primarily involves the skin,with the fundamental pathogenesis of pathogens stagnating in the muscular superficies.Clinically,the treatment is frequently conducted from the perspective of fire-heat syndrome,and the therapeutic methods of clearing heat and removing toxins,releasing muscles and dispersing pathogens from the superficies,and dispelling wind to relieve itching are utilized.The approaches aim to cool heat in the blood,expel pathogens from the muscular layer,eliminate heat for stopping itching,and extinguish wind for calming the skin.The basic prescription,Yinqiao Xingzi Decoction(composed of Lonicerae Japonicae Flos,Forsythiae Fructus,Armeniacae Semen Amarum,Arnebiae Radix,Tribuli Fructus,Dictamni Cortex,Kochiae Fructus,and Glycyrrhizae Radix et Rhizoma),is used by modification depending on the predominance of pathogenic factors of wind,heat,dryness,or dampness-toxins,and according to the various syndromes like blood-heat,yin deficiency,or qi-blood deficiency.Yinqiao Xingzi Decoction is applicable to cutaneous pruritus with the most of clinical common syndrome types,but it is unsuitable for cases caused by yang deficiency or qi stagnation with blood stasis.
9.Development and validation of a machine learning-based prognostic model for portal vein thrombosis in liver cirrhosis
Junqi YUAN ; Sa LYU ; Jun LING ; Yiwen XU ; Hui FENG ; Shaoli YOU ; Fuquan LIU ; Limei YU ; Bing ZHU
Chinese Journal of Hepatobiliary Surgery 2025;31(7):497-502
Objective:To analyze the prognostic factors of patients with liver cirrhosis and portal vein thrombosis (PVT), and to construct a prognostic prediction model based on machine learning methods.Methods:The clinical data of 388 patients with liver cirrhosis and PVT admitted to the Fifth Medical Center of PLA General Hospital from January 2022 to April 2024 were retrospectively collected and analyzed, including 243 males and 145 females, aged (56.9±10.9) years. A total of 388 patients were randomly divided into the training set ( n=310) and the testing set ( n=78) in a 4∶1 ratio. The Boruta algorithm was used to screen the key features in the training set, and then four machine learning algorithms, including random forest, support vector machine, generalized linear model and Bayesian, were used to establish a survival prediction model. Model performance was evaluated by the receiver operating characteristic (ROC) curves of the test set and the training set. The patients were followed up for 1 year for survival. Sort the importance of features based on the SHAP value. Results:There were 250 patients (80.6%) who survived and 60 (19.4%) who died. The model for end-stage liver disease score, total bilirubin, serum creatinine, prothrombin time, international normalized ratio, D-dimer, white blood cell count, severe ascites ratio, and Child-Pugh grade C ratio of liver function in the death group were higher than those in the survival group, and the red blood cell count and hematocrit were lower than those in the survival group, and the differences were statistically significant (all P<0.05). The areas under the ROC curve for predicting survival by random forest, support vector machine, generalized linear model and Bayesian model were 0.92, 0.78, 0.81 and 0.71 in the training set, and the area under the ROC curve in the testing set were 0.81, 0.72, 0.67 and 0.68, respectively. Random forest had the best prediction performance, with an accuracy of 81.7%, a sensitivity of 84.6%, and a specificity of 76.9% in the testing set. In the analysis of the importance of characteristic parameters of the random forest model, total bilirubin, red blood cells, hematocrit, serum creatinine, ascites classification, etc. had a relatively high contribution to the model. Conclusion:In the survival prediction model of patients with liver cirrhosis and PVT based on machine learning algorithm, the random forest model had high prediction performance, and total bilirubin may be the most important factor affecting the survival prognosis of patients.
10.Investigation and management of a clustered incident of incision infection after microtia plastic surgery
Jian SUN ; Zhiyuan CHEN ; Hua XU ; Limei MA ; Weiguang LI
Chinese Journal of Nosocomiology 2025;35(16):2432-2436
OBJECTIVE To summarize the process of investigation,disposal and prevention of a cluster incident of post-operative incision infection following microtia plastic surgery in the otorhinolaryngology department of a terti-ary care hospital,in order to provide a basis for hospital-aquired infection prevention and control.METHODS An epidemiological survey was conducted on seven patients who underwent otorhinolaryngoplasty for microtia in the ENT department of a tertiary care hospital from 27 Jul.to 7 Sep.2023,and interventions were implemented.RESULTS The incidence rate of infection was 71.43%among post-otorhinolaryngoplasty patients.In 5 patients,area for electrocoagulation of haemostatic increased by approximately 50%compared to the previous period,and drainage tubes were left in the surgical area for 11 to 13 days.Patients changed dressings in a shared dressing room.Pseudomonas aeruginosa was detected in three of the infected patients,and their antibiotic sensitivity pat-terns were similar to that of a lower respiratory tract infection patient(case 0)in the same department.CONCLUSION Inadequate aseptic practice by medical staff,longer retention of drainage tubes,incomplete disin-fection of the environment of the dressing room,and changes in surgical procedures may be the primary factors contributing to the occurrence of this cluster of infections.

Result Analysis
Print
Save
E-mail